[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Pulmonary Arterial Hypertension (PAH) Drugs Sales Market Report 2017

August 2017 | 118 pages | ID: G1E6E7BF6A5EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the global Pulmonary Arterial Hypertension (PAH) Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Pulmonary Arterial Hypertension (PAH) Drugs for these regions, from 2012 to 2022 (forecast), covering
  • United States
  • China
  • Europe
  • Japan
  • Southeast Asia
  • India
Global Pulmonary Arterial Hypertension (PAH) Drugs market competition by top manufacturers/players, with Pulmonary Arterial Hypertension (PAH) Drugs sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Actelion Pharmaceuticals
  • DAIICHI SANKYO
  • GlaxoSmithKline
  • Novartis
  • United Therapeutics
  • AADi
  • Actelion Pharmaceuticals
  • Aires Pharmaceuticals
  • Arena Pharmaceuticals
  • Asklepion Pharmaceuticals
  • AstraZeneca
  • Bayer Healthcare
  • Berlin Cures
  • BIAL
  • Eiger BioPharmaceuticals
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
  • Inhalation
  • Injectables
  • Oral administration
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Pulmonary Arterial Hypertension (PAH) Drugs for each application, including
  • ERAs
  • Prostacyclin analogs
  • PDE inhibitors
  • sGC stimulators
Global Pulmonary Arterial Hypertension (PAH) Drugs Sales Market Report 2017

1 PULMONARY ARTERIAL HYPERTENSION (PAH) DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Pulmonary Arterial Hypertension (PAH) Drugs
1.2 Classification of Pulmonary Arterial Hypertension (PAH) Drugs by Product Category
  1.2.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 Global Pulmonary Arterial Hypertension (PAH) Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Inhalation
  1.2.4 Injectables
  1.2.5 Oral administration
1.3 Global Pulmonary Arterial Hypertension (PAH) Drugs Market by Application/End Users
  1.3.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022)
  1.3.2 ERAs
  1.3.3 Prostacyclin analogs
  1.3.4 PDE inhibitors
  1.3.5 sGC stimulators
1.4 Global Pulmonary Arterial Hypertension (PAH) Drugs Market by Region
  1.4.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 United States Pulmonary Arterial Hypertension (PAH) Drugs Status and Prospect (2012-2022)
  1.4.3 China Pulmonary Arterial Hypertension (PAH) Drugs Status and Prospect (2012-2022)
  1.4.4 Europe Pulmonary Arterial Hypertension (PAH) Drugs Status and Prospect (2012-2022)
  1.4.5 Japan Pulmonary Arterial Hypertension (PAH) Drugs Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Status and Prospect (2012-2022)
  1.4.7 India Pulmonary Arterial Hypertension (PAH) Drugs Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Pulmonary Arterial Hypertension (PAH) Drugs (2012-2022)
  1.5.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue and Growth Rate (2012-2022)

2 GLOBAL PULMONARY ARTERIAL HYPERTENSION (PAH) DRUGS COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Market Competition by Players/Suppliers
  2.1.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Pulmonary Arterial Hypertension (PAH) Drugs (Volume and Value) by Type
  2.2.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue and Market Share by Type (2012-2017)
2.3 Global Pulmonary Arterial Hypertension (PAH) Drugs (Volume and Value) by Region
  2.3.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Sales and Market Share by Region (2012-2017)
  2.3.2 Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue and Market Share by Region (2012-2017)
2.4 Global Pulmonary Arterial Hypertension (PAH) Drugs (Volume) by Application

3 UNITED STATES PULMONARY ARTERIAL HYPERTENSION (PAH) DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Pulmonary Arterial Hypertension (PAH) Drugs Sales and Value (2012-2017)
  3.1.1 United States Pulmonary Arterial Hypertension (PAH) Drugs Sales and Growth Rate (2012-2017)
  3.1.2 United States Pulmonary Arterial Hypertension (PAH) Drugs Revenue and Growth Rate (2012-2017)
  3.1.3 United States Pulmonary Arterial Hypertension (PAH) Drugs Sales Price Trend (2012-2017)
3.2 United States Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume and Market Share by Players
3.3 United States Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume and Market Share by Type
3.4 United States Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume and Market Share by Application

4 CHINA PULMONARY ARTERIAL HYPERTENSION (PAH) DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 China Pulmonary Arterial Hypertension (PAH) Drugs Sales and Value (2012-2017)
  4.1.1 China Pulmonary Arterial Hypertension (PAH) Drugs Sales and Growth Rate (2012-2017)
  4.1.2 China Pulmonary Arterial Hypertension (PAH) Drugs Revenue and Growth Rate (2012-2017)
  4.1.3 China Pulmonary Arterial Hypertension (PAH) Drugs Sales Price Trend (2012-2017)
4.2 China Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume and Market Share by Players
4.3 China Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume and Market Share by Type
4.4 China Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume and Market Share by Application

5 EUROPE PULMONARY ARTERIAL HYPERTENSION (PAH) DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Pulmonary Arterial Hypertension (PAH) Drugs Sales and Value (2012-2017)
  5.1.1 Europe Pulmonary Arterial Hypertension (PAH) Drugs Sales and Growth Rate (2012-2017)
  5.1.2 Europe Pulmonary Arterial Hypertension (PAH) Drugs Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Pulmonary Arterial Hypertension (PAH) Drugs Sales Price Trend (2012-2017)
5.2 Europe Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume and Market Share by Players
5.3 Europe Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume and Market Share by Type
5.4 Europe Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume and Market Share by Application

6 JAPAN PULMONARY ARTERIAL HYPERTENSION (PAH) DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Pulmonary Arterial Hypertension (PAH) Drugs Sales and Value (2012-2017)
  6.1.1 Japan Pulmonary Arterial Hypertension (PAH) Drugs Sales and Growth Rate (2012-2017)
  6.1.2 Japan Pulmonary Arterial Hypertension (PAH) Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Pulmonary Arterial Hypertension (PAH) Drugs Sales Price Trend (2012-2017)
6.2 Japan Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume and Market Share by Players
6.3 Japan Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume and Market Share by Type
6.4 Japan Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume and Market Share by Application

7 SOUTHEAST ASIA PULMONARY ARTERIAL HYPERTENSION (PAH) DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Sales and Value (2012-2017)
  7.1.1 Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Sales Price Trend (2012-2017)
7.2 Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume and Market Share by Players
7.3 Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume and Market Share by Type
7.4 Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume and Market Share by Application

8 INDIA PULMONARY ARTERIAL HYPERTENSION (PAH) DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 India Pulmonary Arterial Hypertension (PAH) Drugs Sales and Value (2012-2017)
  8.1.1 India Pulmonary Arterial Hypertension (PAH) Drugs Sales and Growth Rate (2012-2017)
  8.1.2 India Pulmonary Arterial Hypertension (PAH) Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 India Pulmonary Arterial Hypertension (PAH) Drugs Sales Price Trend (2012-2017)
8.2 India Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume and Market Share by Players
8.3 India Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume and Market Share by Type
8.4 India Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume and Market Share by Application

9 GLOBAL PULMONARY ARTERIAL HYPERTENSION (PAH) DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Actelion Pharmaceuticals
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Pulmonary Arterial Hypertension (PAH) Drugs Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Actelion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 DAIICHI SANKYO
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Pulmonary Arterial Hypertension (PAH) Drugs Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 DAIICHI SANKYO Pulmonary Arterial Hypertension (PAH) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 GlaxoSmithKline
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Pulmonary Arterial Hypertension (PAH) Drugs Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Novartis
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Pulmonary Arterial Hypertension (PAH) Drugs Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Novartis Pulmonary Arterial Hypertension (PAH) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 United Therapeutics
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Pulmonary Arterial Hypertension (PAH) Drugs Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 United Therapeutics Pulmonary Arterial Hypertension (PAH) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 AADi
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Pulmonary Arterial Hypertension (PAH) Drugs Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 AADi Pulmonary Arterial Hypertension (PAH) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 Actelion Pharmaceuticals
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Pulmonary Arterial Hypertension (PAH) Drugs Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Actelion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 Aires Pharmaceuticals
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Pulmonary Arterial Hypertension (PAH) Drugs Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Aires Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 Arena Pharmaceuticals
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Pulmonary Arterial Hypertension (PAH) Drugs Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Arena Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 Asklepion Pharmaceuticals
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Pulmonary Arterial Hypertension (PAH) Drugs Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 Asklepion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview
9.11 AstraZeneca
9.12 Bayer Healthcare
9.13 Berlin Cures
9.14 BIAL
9.15 Eiger BioPharmaceuticals

10 PULMONARY ARTERIAL HYPERTENSION (PAH) DRUGS MAUFACTURING COST ANALYSIS

10.1 Pulmonary Arterial Hypertension (PAH) Drugs Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Pulmonary Arterial Hypertension (PAH) Drugs
10.3 Manufacturing Process Analysis of Pulmonary Arterial Hypertension (PAH) Drugs

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Pulmonary Arterial Hypertension (PAH) Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Pulmonary Arterial Hypertension (PAH) Drugs Major Manufacturers in 2016
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL PULMONARY ARTERIAL HYPERTENSION (PAH) DRUGS MARKET FORECAST (2017-2022)

14.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume and Growth Rate Forecast (2017-2022)
  14.1.2 Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Pulmonary Arterial Hypertension (PAH) Drugs Price and Trend Forecast (2017-2022)
14.2 Global Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  14.2.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume and Growth Rate Forecast by Regions (2017-2022)
  14.2.2 Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.3 United States Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 China Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Europe Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 Japan Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.7 Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.8 India Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume, Revenue and Price Forecast by Type (2017-2022)
  14.3.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Sales Forecast by Type (2017-2022)
  14.3.2 Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue Forecast by Type (2017-2022)
  14.3.3 Global Pulmonary Arterial Hypertension (PAH) Drugs Price Forecast by Type (2017-2022)
14.4 Global Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Pulmonary Arterial Hypertension (PAH) Drugs
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Comparison (K Units) by Type (2012-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Inhalation Product Picture
Figure Injectables Product Picture
Figure Oral administration Product Picture
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Sales Comparison (K Units) by Application (2012-2022)
Figure Global Sales Market Share of Pulmonary Arterial Hypertension (PAH) Drugs by Application in 2016
Figure ERAs Examples
Figure Prostacyclin analogs Examples
Figure PDE inhibitors Examples
Figure sGC stimulators Examples
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Market Size (Million USD) by Regions (2012-2022)
Figure United States Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume (K Units) (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Pulmonary Arterial Hypertension (PAH) Drugs Sales Share by Players/Suppliers
Figure 2017 Pulmonary Arterial Hypertension (PAH) Drugs Sales Share by Players/Suppliers
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue Share by Players
Table 2017 Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue Share by Players
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Sales (K Units) and Market Share by Type (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Sales Share (K Units) by Type (2012-2017)
Figure Sales Market Share of Pulmonary Arterial Hypertension (PAH) Drugs by Type (2012-2017)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Sales Growth Rate by Type (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Pulmonary Arterial Hypertension (PAH) Drugs by Type (2012-2017)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Pulmonary Arterial Hypertension (PAH) Drugs by Region (2012-2017)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Sales Growth Rate by Region in 2016
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Pulmonary Arterial Hypertension (PAH) Drugs by Region (2012-2017)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue Growth Rate by Region in 2016
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Pulmonary Arterial Hypertension (PAH) Drugs by Region (2012-2017)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue Market Share by Region in 2016
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Pulmonary Arterial Hypertension (PAH) Drugs by Application (2012-2017)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Sales Market Share by Application (2012-2017)
Figure United States Pulmonary Arterial Hypertension (PAH) Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure United States Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Pulmonary Arterial Hypertension (PAH) Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table United States Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume (K Units) by Players (2012-2017)
Table United States Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Players (2012-2017)
Figure United States Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Players in 2016
Table United States Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume (K Units) by Type (2012-2017)
Table United States Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Type (2012-2017)
Figure United States Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Type in 2016
Table United States Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume (K Units) by Application (2012-2017)
Table United States Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Application (2012-2017)
Figure United States Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Application in 2016
Figure China Pulmonary Arterial Hypertension (PAH) Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure China Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Pulmonary Arterial Hypertension (PAH) Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table China Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume (K Units) by Players (2012-2017)
Table China Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Players (2012-2017)
Figure China Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Players in 2016
Table China Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume (K Units) by Type (2012-2017)
Table China Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Type (2012-2017)
Figure China Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Type in 2016
Table China Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume (K Units) by Application (2012-2017)
Table China Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Application (2012-2017)
Figure China Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Application in 2016
Figure Europe Pulmonary Arterial Hypertension (PAH) Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Pulmonary Arterial Hypertension (PAH) Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Europe Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume (K Units) by Players (2012-2017)
Table Europe Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Players (2012-2017)
Figure Europe Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Players in 2016
Table Europe Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume (K Units) by Type (2012-2017)
Table Europe Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Type (2012-2017)
Figure Europe Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Type in 2016
Table Europe Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume (K Units) by Application (2012-2017)
Table Europe Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Application (2012-2017)
Figure Europe Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Application in 2016
Figure Japan Pulmonary Arterial Hypertension (PAH) Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Pulmonary Arterial Hypertension (PAH) Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume (K Units) by Players (2012-2017)
Table Japan Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Players (2012-2017)
Figure Japan Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Players in 2016
Table Japan Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume (K Units) by Type (2012-2017)
Table Japan Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Type in 2016
Table Japan Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume (K Units) by Application (2012-2017)
Table Japan Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume (K Units) by Players (2012-2017)
Table Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Players in 2016
Table Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume (K Units) by Application (2012-2017)
Table Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Application in 2016
Figure India Pulmonary Arterial Hypertension (PAH) Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure India Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Pulmonary Arterial Hypertension (PAH) Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table India Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume (K Units) by Players (2012-2017)
Table India Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Players (2012-2017)
Figure India Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Players in 2016
Table India Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume (K Units) by Type (2012-2017)
Table India Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Type (2012-2017)
Figure India Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Type in 2016
Table India Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume (K Units) by Application (2012-2017)
Table India Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Application (2012-2017)
Figure India Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share by Application in 2016
Table Actelion Pharmaceuticals Basic Information List
Table Actelion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Actelion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Sales Growth Rate (2012-2017)
Figure Actelion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Sales Global Market Share (2012-2017
Figure Actelion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Revenue Global Market Share (2012-2017)
Table DAIICHI SANKYO Basic Information List
Table DAIICHI SANKYO Pulmonary Arterial Hypertension (PAH) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure DAIICHI SANKYO Pulmonary Arterial Hypertension (PAH) Drugs Sales Growth Rate (2012-2017)
Figure DAIICHI SANKYO Pulmonary Arterial Hypertension (PAH) Drugs Sales Global Market Share (2012-2017
Figure DAIICHI SANKYO Pulmonary Arterial Hypertension (PAH) Drugs Revenue Global Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Drugs Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Drugs Sales Global Market Share (2012-2017
Figure GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Drugs Revenue Global Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Pulmonary Arterial Hypertension (PAH) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Pulmonary Arterial Hypertension (PAH) Drugs Sales Growth Rate (2012-2017)
Figure Novartis Pulmonary Arterial Hypertension (PAH) Drugs Sales Global Market Share (2012-2017
Figure Novartis Pulmonary Arterial Hypertension (PAH) Drugs Revenue Global Market Share (2012-2017)
Table United Therapeutics Basic Information List
Table United Therapeutics Pulmonary Arterial Hypertension (PAH) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure United Therapeutics Pulmonary Arterial Hypertension (PAH) Drugs Sales Growth Rate (2012-2017)
Figure United Therapeutics Pulmonary Arterial Hypertension (PAH) Drugs Sales Global Market Share (2012-2017
Figure United Therapeutics Pulmonary Arterial Hypertension (PAH) Drugs Revenue Global Market Share (2012-2017)
Table AADi Basic Information List
Table AADi Pulmonary Arterial Hypertension (PAH) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AADi Pulmonary Arterial Hypertension (PAH) Drugs Sales Growth Rate (2012-2017)
Figure AADi Pulmonary Arterial Hypertension (PAH) Drugs Sales Global Market Share (2012-2017
Figure AADi Pulmonary Arterial Hypertension (PAH) Drugs Revenue Global Market Share (2012-2017)
Table Actelion Pharmaceuticals Basic Information List
Table Actelion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Actelion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Sales Growth Rate (2012-2017)
Figure Actelion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Sales Global Market Share (2012-2017
Figure Actelion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Revenue Global Market Share (2012-2017)
Table Aires Pharmaceuticals Basic Information List
Table Aires Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Aires Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Sales Growth Rate (2012-2017)
Figure Aires Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Sales Global Market Share (2012-2017
Figure Aires Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Revenue Global Market Share (2012-2017)
Table Arena Pharmaceuticals Basic Information List
Table Arena Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Arena Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Sales Growth Rate (2012-2017)
Figure Arena Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Sales Global Market Share (2012-2017
Figure Arena Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Revenue Global Market Share (2012-2017)
Table Asklepion Pharmaceuticals Basic Information List
Table Asklepion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Asklepion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Sales Growth Rate (2012-2017)
Figure Asklepion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Sales Global Market Share (2012-2017
Figure Asklepion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Revenue Global Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table Bayer Healthcare Basic Information List
Table Berlin Cures Basic Information List
Table BIAL Basic Information List
Table Eiger BioPharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pulmonary Arterial Hypertension (PAH) Drugs
Figure Manufacturing Process Analysis of Pulmonary Arterial Hypertension (PAH) Drugs
Figure Pulmonary Arterial Hypertension (PAH) Drugs Industrial Chain Analysis
Table Raw Materials Sources of Pulmonary Arterial Hypertension (PAH) Drugs Major Players in 2016
Table Major Buyers of Pulmonary Arterial Hypertension (PAH) Drugs
Table Distributors/Traders List
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Price (USD/Unit) and Trend Forecast (2017-2022)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume (K Units) Forecast by Regions (2017-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share Forecast by Regions in 2022
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue Market Share Forecast by Regions in 2022
Figure United States Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure China Pulmonary Arterial Hypertension (PAH) Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure India Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Sales (K Units) Forecast by Type (2017-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Price (USD/Unit) Forecast by Type (2017-2022)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories